Induction of T-kininogen and tumor necrosis factor-α by macrophage migration inhibitory factor in vivo

Seminars in Thrombosis and Hemostasis

Volumn 25, Issue 6, 1999, Pages 557-562

  Nishihira, Jun ^a   Mizue, Yuka ^b   Sakamoto, Wataru ^c  

^a HOKKAIDO UNIVERSITY   (Japan)

^b Sapporo Immuno Diagnostic Laboratory   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Lipopolysaccharide; Macrophage migration inhibitory factor; Tissue injury; Tumor necrosis factor

Indexed keywords

ENDOTOXIN; IMMUNOGLOBULIN G; KININOGEN; LIPOPOLYSACCHARIDE; MACROPHAGE MIGRATION INHIBITION FACTOR; MACROPHAGE MIGRATION INHIBITION FACTOR ANTIBODY; T KININOGEN; UNCLASSIFIED DRUG;

ACUTE PHASE RESPONSE; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; IMMUNOREGULATION; INFLAMMATION; MACROPHAGE MIGRATION INHIBITION; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN INDUCTION; RAT; THROMBOCYTE COUNT;

EID: 0033450985     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-994965     Document Type: Article

References (29)

1. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975;72:3666-3670
2. Fujioka N, Mukaida N, Harada A, et al. Preparation of specific antibodies against murine IL-Ira and the establishment of IL-Ira as an endogenous regulator of bacteria-induced fulminant hepatitis in mice. J Leukocyte Biol 1995;58:90-98
3. Okamura H, Tsutsi H, Komatsu T, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995;378:88-91
4. Pettinger WA, Young R. Endotoxin-induced kinin (bradykinin) formation: Activation of Hageman factor and plasma kallikrein in human plasma. Life Sci 1970;9:313-322
5. Müller-Esterl W, Iwanaga S, Nakanishi S. Kininogens revisited. Trends Biochem Sci 1986;11:336-339
6. Bedi GS, Balwierczack J, Back N. A new vasopeptide formed by the action of a murphy-sturm Iymphosarcoma acid protease on rat plasma kininogen. Biochem Biophys Res Commun 1983;12:621-628
7. Okamoto H, Greenbaum LM. Isolation and structure of T-kinin. Biochem Biophys Res Commun 1983;112:701-708
8. Greenbaum LM, Okamoto H. T-kinin and T-kininogen. Methods Enzymol 1988;163:272-282
9. Bloom BR, Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 1966;153:80-82
10. David JR. Delayed hypersensitivity in vitro: Its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci USA 1966;56:72-77
11. Bernhagen J, Calandra T, Mitchell RA, et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 1993;365:756-759
12. Calandra T, Bernhagen, J, Metz CN, et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995; 377:68-71
13. Bacher M, Metz CN, Calandra T, et al. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci USA 1996;93:7849-7854
14. Calandra T, Bernhagen J, Mitchell RA, Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 1994;179: 1895-1902
15. Nishihira J, Koyama Y, Mizue Y. Identification of macrophage migration inhibitory factor (MIF) in human vascular endothelial cells and its induction by lipopolysaccharide. Cytokine 1998;10:199-205
16. Onodera S, Suzuki K, Matsuno T, et al. Identification of macrophage migration inhibitory factor in murine neonatal calvariae and osteoblasts. Immunology 1996;89:430-435
17. Bacher M, Meinhardt A, Lan HY, et al. Migration inhibitory factor expression in experimentally induced endotoxemia. Am J Pathol 1997;150:235-246
18. Sakamoto W, Kaga M, Handa H, et al. Bradykinin and Met-T-kinin-Leu stimulated PGE2 production by rat macrophage and fibroblast. Brazilian J Med Biol Res 1994;27:1923-1927
19. Nishihira J, Kuriyama T, Sakai M, et al. The structure and physicochemical properties of rat liver macrophage migration inhibitory factor. Biochim Biophys Acta 1995;1247:159-162
20. Sakamoto W, Yoshikawa K, Uehara S, Nishikaze O, Handa HJ. Purification and characterization of rat low molecular weight kininogen. J Biochem 1984;96:81-88
21. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685
22. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-275
23. Donnelly SC, Haslett C, Reid PT, et al. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nature Med 1997;3:320-323
24. Makita H, Nishimura M, Miyamoto K, et al. Effect of anti-macrophage migration inhibitory factor antibody on LPS-induced pulmonary neutrophil accumulation. Am J Respir Crit Care Med 1998;158:573-579
25. Chao J, Swain C, Chao S, Xiong W, Chao L. Tissue distribution and kininogen gene expression after acute-phase inflammation. Biochem Biophys Acta 1988;964:329-339
26. Okamoto H, Greenbaum LM. Pharmacological properties of T-kinin (isoleucyl-seryl-bradykinin) from rat plasma. Biochem Pharmacol 1983;32:2637-2638
27. Koj A. Initiation of acute phase response and synthesis of cytokines. Biochim Biophys Acta 1996;1317:84-94
28. Sueyoshi T, Enjyoji K, Shimada T, et al. A new function of kininogens as thiol-proteinase inhibitors: Inhibition of papain and cathepsins B, H and L by bovine, rat and human plasma kininogens. FEBS Lett 1985;182:193-195
29. Matsuda A, Tagawa Y, Matsuda H, Nishihira J. Expression of macrophage migration inhibitory factor in rat corneal wound healing. Invest Ophthalmol Vis Sci 1997;38:1555-1562